首页>
外国专利>
L-FABP, NATRIURETIC PEPTIDES AND CARDIAC TROPONIN IN INDIVIDUALS IN NEED FOR A CARDIAC THERAPY
L-FABP, NATRIURETIC PEPTIDES AND CARDIAC TROPONIN IN INDIVIDUALS IN NEED FOR A CARDIAC THERAPY
展开▼
机译:需要进行心脏治疗的个体中的L-FABP,利钠肽和心脏肌钙蛋白
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a method for identifying a subject being susceptible to a cardiac therapy, comprising (a) determining the amounts of liver fatty acid binding protein, and at least one further polypeptide from the group of a cardiac troponin and a natriuretic peptide in at least one sample of a subject suffering from heart failure, (b) comparing the, thus, determined amounts to suitable reference amounts, and (c) identifying a subject being susceptible to a cardiac therapy. Moreover, the present invention relates to a device and a kit adapted to carry out the method of the present invention. Also encompassed by the present invention is the use of liver fatty acid binding protein and at least one further polypeptide from the group of a cardiac troponin and a natriuretic peptide for identifying a subject being susceptible to a cardiac therapy.
展开▼